| 1 | CSS1, FAS
|
| The molecular basis for apoptotic defects in patients with CD95 (Fas/Apo-1) mutations.
|
| Vaishnaw AK, et al.
|
| J Clin Invest 103(3):355-63. 1999
|
| 2 | CSS1, FAS
|
| Defective CD95/APO-1/Fas signal complex formation in the human autoimmune lymphoproliferative syndrome, type Ia.
|
| Martin DA, et al.
|
| Proc Natl Acad Sci U S A 96(8):4552-7. 1999
|
| 3 | CSS1, FAS
|
| Novel Fas (CD95/APO-1) mutations in infants with a lymphoproliferative disorder.
|
| Kasahara Y, et al.
|
| Int Immunol 10(2):195-202. 1998
|
| 4 | CSS1, FAS
|
| Missense mutations in the Fas gene resulting in autoimmune lymphoproliferative syndrome : a molecular and immunological analysis.
|
| Bettinardi A, et al.
|
| Blood 89 : 902-909. 1997
|
| 5 | CSS1, FAS
|
| Clinical, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis.
|
| Sneller MC, et al.
|
| Blood 89(4):1341-8. 1997
|
| 6 | CSS2, CSS1, FAS
|
| Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity.
|
| Drappa J, et al.
|
| N Engl J Med 335(22):1643-9. 1996
|
| 7 | FAS, CSS1
|
| Mutations in fas associated with human lymphoproliferative syndrome and autoimmunity.
|
| Rieux-Laucat F, et al.
|
| Science 268 : 1347-1349. 1995
|
| 8 | CSS1, FAS
|
| Dominant interfering fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome.
|
| Fisher GH, et al.
|
| Cell 81 : 935-946. 1995
|